Analysts Set ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) Target Price at $29.00
ARS Pharmaceuticals, Inc. (NASDAQ:SPRY – Get Free Report) has earned an average rating of “Buy” from the seven analysts that are presently covering the firm, MarketBeat Ratings reports. Six analysts have rated the stock with a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1 year target price […]
ARS Pharmaceuticals, Inc. (NASDAQ:SPRY – Get Free Report) has earned an average rating of “Buy” from the seven analysts that are presently covering the firm, MarketBeat Ratings reports. Six analysts have rated the stock with a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1 year target price […]
